Discover trends, market shifts, and competitive outlooks for the metabolomics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Metabolomics Market Size Shifted, And What Is the Outlook Through 2034?

In the past few years, the size of the metabolomics market has experienced robust growth. There is a projected increase from $3.62 billion in 2024 to $4.18 billion in 2025, showcasing a compound annual growth rate (CAGR) of 15.4%. The historical growth trend is due to various factors such as improvements in healthcare, advancements in drug discovery and development, the identification of disease biomarkers, as well as the contributions from academic and research institutions in the field of nutrition and food science.

The market size of metabolomics is projected to undergo significant expansion in the forthcoming years, escalating to $7.99 billion by 2029 with a 17.6% Compound Annual Growth Rate (CAGR). The growth throughout this forecasted period is mainly driven by factors like personalized healthcare, drug safety and efficiency, microbiome and gut health, as well as environmental and agricultural applications and regenerative medicine. The forecast period is likely to witness several major trends such as integration with other omics, targeted metabolomics, single-cell metabolomics, data analytics, artificial intelligence, and point-of-care testing.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2497&type=smp

What are the Fundamental Drivers and Innovations Shaping the Metabolomics Market?

The metabolomics market is expanding due to the escalating prevalence rate of cancer. The method of metabolomics aids in identifying potential biomarkers (specific cells, molecules, genes, or gene products, enzymes, or hormones) that ascertain the responsiveness to cancer medication and facilitate early diagnosis. For example, the American Cancer Society, a professional organization in the US, predicts that in 2023, the number of new cancer cases will reach 1,958,310 and cancer-related deaths will total 609,820, a rise from the preceding year. Techniques like nuclear magnetic resonance (NMR) and mass spectrometry (MS) have become staple tools in studying cancer under metabolomics. Companies such as Metabolon Inc., Bruker Corp., and others have embraced the use of metabolomics for early cancer detection and treatment.

How Is the Metabolomics Market Segmented?

The metabolomics market covered in this report is segmented –

1) By Product And Service: Metabolomics Instruments, Metabolomics Bioinformatics Tools And Services

2) By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Other Indications

3) By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications

Subsegments:

1) By Metabolomics Instruments: Chromatography Instruments (Gas Chromatography, Liquid Chromatography), Mass Spectrometry Instruments (LC-MS, GC-MS), NMR Instruments (Nuclear Magnetic Resonance), Others (Spectroscopy Instruments, Microarrays)

2) By Metabolomics Bioinformatics Tools And Services: Software Tools (Data Analysis, Statistical Tools, Modeling Tools), Database Services (Metabolomic Databases), Consulting Services (Data Interpretation, Analytical Support), Training And Support Services

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2497&type=smp

Which Regions Are Driving the Next Phase of the Metabolomics Market Growth?

North America was the largest region in the metabolomics market in 2023. Western Europe was the second largest region in the metabolomics market. The regions covered in the metabolomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Long-Term Trends Are Transforming the Competitive Landscape of the Metabolomics Market?

There’s a growing trend of employing machine learning in the metabolomics sector as it enhances the efficacy of data interpretation generated from metabolomics techniques. Automating risky and complex procedures, eliminating repetitive and time-consuming processes, and offering swift and accurate services are possible with technologies powered by machine learning. These techniques are preferred by companies in this industry for metabolism analysis, problem-solving, process automation and task execution. Several machine learning algorithms assist in metabolism data analysis and metabolic pathway modelling. Businesses like Bio-Rad Laboratories and Metabolon Inc. are starting to utilise machine learning algorithms for a deeper understanding and future predictions in metabolomics studies. For instance, MeltDB 2.0, a machine learning software, serves as a tool to analyse and integrate metabolomics experiment data, thereby supporting research and storage of experimental data sets. This type of machine learning software provides extensive analysis and visualization tools, essential for effectively presenting large, complex data.

View the full report here:

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

How Is the Metabolomics Market Defined and What Are Its Core Parameters?

Metabolomics is the study of small molecules called metabolites that are produced during metabolism within cells, tissues, or organisms. It provides insights into biological processes, disease mechanisms, and metabolic pathways by analyzing and quantifying these metabolites. This field is crucial in personalized medicine, drug discovery, and understanding various diseases like cancer and diabetes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2497

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model